The Dominance of Pharmaceutical Therapies in Managing the Type 2 Patient Pool The vast majority of individuals living with the chronic metabolic condition in the country have the Type 2 variant, which is strongly linked to urbanization, sedentary lifestyles, and dietary changes. Consequently, the pharmaceutical segment focused on non-insulin treatments holds a dominant share of the therapeutic...